M. Schweri

发表

Quantitative structure-activity relationship studies of threo-methylphenidate analogs.

E. Gruszecka-Kowalik, M. Misra, H. Deutsch, 2010, Bioorganic & medicinal chemistry.

An in vitro binding assay which differentiates benzodiazepine 'agonists' and 'antagonists'.

S. Paul, P. Skolnick, M. Schweri, 1982, European journal of pharmacology.

[3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex.

S. Paul, A. Janowsky, P. Skolnick, 1985, European journal of pharmacology.

The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.

S. Paul, A. Janowsky, P. Skolnick, 1985, European journal of pharmacology.

[3H]Threo‐(±)‐Methylphenidate Binding to 3,4‐Dihydroxyphenylethylamine Uptake Sites in Corpus Striatum: Correlation with the Stimulant Properties of Ritalinic Acid Esters

S. Paul, A. Janowsky, P. Skolnick, 1985, Journal of neurochemistry.

N-ethylmaleimide irreversibly inhibits the binding of [3H]threo-(±)-methylphenidate to the stimulant recognition site

M. Schweri, 1990, Neuropharmacology.

The effects of cycloheximide and anisomycin on monoamine synthesis in a brain synaptosome preparation

L. Carr, M. Schweri, 2005, Journal of Neural Transmission.

Effects of amino acid alterations caused by protein synthesis inhibitors on brain monoamine formation

L. Carr, M. Schweri, 1982, Neuropharmacology.

Radial diffusion assay of tissue collagenase and its application in evaluation of collagenase inhibitors.

J. A. Yankeelov, M. Schweri, W. Wacker, 1977, Biochimica et biophysica acta.

Pharmacokinetic and pharmacodynamic factors contributing to the convulsant action of β-carboline-3-carboxylic acid esters

S. Paul, J. Barrett, W. Mendelson, 1983 .

3-carboethoxy-β-carboline (β-CCE) elicits electroencephalographic seizures in rats: Reversal by the benzodiazepine antagonist CGS 8216

S. Paul, W. Mendelson, P. Skolnick, 1983 .

Blockade of 3-carbomethoxy-β-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS 8216

S. Paul, P. Skolnick, M. Cain, 1982, Pharmacology Biochemistry and Behavior.

Further evidence for a dopamine reuptake pharmacophore. The effect of N-methylation on Threo-methylphenidate and its analogs

C. George, M. Froimowitz, R. Glaser, 1997 .

Biomimetic approach to potential benzodiazepine receptor agonists and antagonists.

S. Paul, P. Skolnick, M. Cain, 1984, Journal of medicinal chemistry.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-(aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane dopamine uptake inhibitors.

D. Collard, H. Deutsch, L. Zhang, 1999, Journal of medicinal chemistry.

Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs.

E. Gruszecka-Kowalik, H. Deutsch, Q. Shi, 1996, Journal of medicinal chemistry.

Can stimulant binding and dopamine transport be differentiated? Studies with GBR 12783 derivatives.

H. Deutsch, M. Schweri, 1994, Life sciences.

Synthesis and pharmacology of irreversible affinity labels as potential cocaine antagonists: aryl 1,4-dialkylpiperazines related to GBR-12783.

C. Culbertson, H. Deutsch, L. Zalkow, 1992, European journal of pharmacology.

Effects of Methylphenidate Analogues on Phenethylamine Substrates for the Striatal Dopamine Transporter

H. Deutsch, J. O. Schenk, M. Schweri, 1999, Journal of neurochemistry.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.

H. Deutsch, X. Ye, M. Schweri, 2007, Journal of medicinal chemistry.

Inhibition of [3H]Diazepam and [3H]3‐Carboethoxy‐β‐Carboline Binding by Irazepine: Evidence for Multiple “Domains” of the Benzodiazepine Receptor

S. Paul, P. Skolnick, M. Schweri, 1982, Journal of neurochemistry.

Mercuric chloride and p‐chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [3H]methylphenidate to the dopamine transporter

M. Schweri, 1994, Synapse.

Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter.

K. Rice, M. Mattson, A. Thurkauf, 1992, The Journal of pharmacology and experimental therapeutics.

Fourphit, an Acylating Phencyclidine Derivative, Attenuates Cocaine-Induced Hyperactivity in Rats

K. Rice, B. Costa, M. Schweri, 1998, Pharmacology Biochemistry and Behavior.

Amelioration of pseudobulbar affect by fluoxetine: possible alteration of dopamine-related pathophysiology by a selective serotonin reuptake inhibitor.

E. Lauterbach, M. Schweri, 1991, Journal of clinical psychopharmacology.

Biochemical and behavioral characterization of novel methylphenidate analogs.

H. Deutsch, S. Holtzman, M. Schweri, 2002, The Journal of pharmacology and experimental therapeutics.

Synthesis and pharmacology of site specific cocaine abuse treatment agents: a new synthetic methodology for methylphenidate analogs based on the Blaise reaction.

H. Deutsch, Q. Shi, X. Ye, 2001, European journal of medicinal chemistry.

Strain differences in susceptibility to the convulsant actions of 3-carbomethoxy-β-carboline

S. Paul, P. Skolnick, M. Schweri, 1983, Pharmacology Biochemistry and Behavior.

Metaphit Irreversibly Inhibits [3H]threo‐ (±)‐Methylphenidate Binding to Rat Striatal Tissue

K. C. Rice, A. E. Jacobson, M. Schweri, 1987, Journal of neurochemistry.